Home
About
Overview
Sharing Data
ORCID
Help
History (26)
Hepatocyte Nuclear Factor 1-alpha
Matrix Metalloproteinases, Membrane-Associated
Sulpiride
Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells.
Valuing cure: bridging cost-effectiveness and coverage decisions for hepatitis C therapy.
See All 26 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Valuing cure: bridging cost-effectiveness and coverage decisions for hepatitis C therapy.
Valuing cure: bridging cost-effectiveness and coverage decisions for hepatitis C therapy. Hepatology. 2014 Jul; 60(1):12-4.
View in:
PubMed
subject areas
Drug Costs
Hepacivirus
Hepatitis C, Chronic
Heterocyclic Compounds, 3-Ring
Humans
Ribavirin
Simeprevir
Sofosbuvir
Sulfonamides
Uridine Monophosphate
authors with profiles
Mai Tuyet Pho